The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease
Open accessAbstract
The amyloid hypothesis of Alzheimer's disease (AD) postulates that amyloid-β (Aβ) deposition and neurotoxicity play a causative role in AD; oxidative injury is thought to be central in the pathogenesis. An endogenous defense system against oxidative stress is induced by binding of the transcription factor nuclear factor E2-related factor 2 (Nrf2) to the antioxidant response element (ARE) enhancer sequence. The Nrf2-ARE pathway is activated in response to reactive oxygen species to trigger the simultaneous expression of numerous protective enzymes and scavengers. To exploit the Nrf2-ARE pathway therapeutically, we delivered Nrf2 bilaterally into the hippocampus of 9-month-old transgenic AD mice (APP/PS1 mice) using a lentiviral vector encoding human Nrf2. The data indicate that significant reductions in spatial learning deficits of aged APP/PS1 mice in a Morris Water Maze can be achieved by modulating levels of Nrf2 in the brain. Memory improvement in APP/PS1 mice after Nrf2 transduction shifts the balance between soluble and insoluble Aβ toward an insoluble Aβ pool without concomitant change in total brain Aβ burden. Nrf2 gene transfer is associated with a robust reduction in astrocytic but not microglial activation and induction of Nrf2 target gene heme oxygenase 1, indicating overall activation of the Nrf2-ARE pathway in hippocampal neurons 6 months after injection. Results warrant further exploration of the Nrf2-ARE pathway for treatment of AD and suggest that the Nrf2-ARE pathway may represent a potential therapeutic strategy to pursue in AD in humans, particularly in view of the multiple mechanisms by which Nrf2 can exert its protective effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“The amyloid hypothesis of AD postulates that amyloid- (A ) deposition and neurotoxicity play a causative role in AD (1).”
BackgroundAlzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 9×
“An essential step in the activation of the Nrf2-ARE pathway is the liberation of Nrf2 from the cytosolic repressor Keap1 (13), by means of which Nrf2 escapes proteasomal degradation and translocates to the nucleus to activate the expression of cytoprotective genes.”
BackgroundInfluentialMoi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element
Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140229 · Cited by 1,236
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141 · cited 1×
“Nrf2 has a relatively rapid turnover (half-life 20 min), and its activity is regulated by the repressor protein Keap1, which targets Nrf2 for proteosomal degradation (21, 22).”
BackgroundExpression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Regulation of γ-Glutamylcysteine Synthetase Subunit Gene Expression by the Transcription Factor Nrf2
Wild, A. C., Moinova, H. R., & Mulcahy, R. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33627 · Cited by 597
The Nrf2–ARE Pathway: An Indicator and Modulator of Oxidative Stress in Neurodegeneration
Johnson, J. A., Johnson, D. A., Kraft, A. D., Calkins, M. J., Jakel, R. J., Vargas, M. R., & Chen, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.036 · Cited by 589
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
Frautschy, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00300-1 · Cited by 514
Lindholm, D., Castrén, E., Kiefer, R., Zafra, F., & Thoenen, H. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.2.395 · Cited by 487
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Stewart, D., Killeen, E., Naquin, R., Alam, S., & Alam, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209195200 · Cited by 463
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426 · cited 1×
“This finding is of interest as microglial functions are closely related to oxidative stress (25) and thereby potentially to the Nrf2-ARE pathway (26).”
BackgroundBrain oxidative stress in a triple-transgenic mouse model of Alzheimer disease
Resende, R., Moreira, P. I., Proença, T., Deshpande, A., Busciglio, J., Pereira, C., & Oliveira, C. R. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.012 · Cited by 343
Oxidative stress in Alzheimer's disease
Chauhan, V., & Chauhan, A. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.004 · Cited by 342
Choi, J., Rees, H. D., Weintraub, S. T., Levey, A. I., Chin, L.-S., & Li, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414327200 · Cited by 291
Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303592200 · Cited by 280
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
Kanninen, K., Malm, T. M., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M., Ylä-Herttuala, S., Levonen, A.-L., & Koistinaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 255
Self-citationMechanisms of Aβ mediated neurodegeneration in Alzheimer's disease
Crouch, P. J., Harding, S.-M. E., White, A. R., Camakaris, J., Bush, A. I., & Masters, C. L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.013 · Cited by 244
Role of Nrf2 in protection against intracerebral hemorrhage injury in mice
Wang, J., Fields, J., Zhao, C., Langer, J., Thimmulappa, R. K., Kensler, T. W., Yamamoto, M., Biswal, S., & Doré, S. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.020 · Cited by 224
A genomic screen for activators of the antioxidant response element
Liu, Y., Kern, J. T., Walker, J. R., Johnson, J. A., Schultz, P. G., & Luesch, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700898104 · Cited by 196
PONKA, P. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199910000-00004 · Cited by 182
Malm, T., Iivonen, H., Goldsteins, G., Keksa-Goldsteine, V., Ahtoniemi, T., Kanninen, K. M., Salminen, A., Auriola, S. O. K., van Groen, T., Tanila, H., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0059-07.2007 · Cited by 173
Self-citationSzekely, C. A., Green, R. C., Breitner, J. C. S., Østbye, T., Beiser, A. S., Corrada, M. M., Dodge, H. H., Ganguli, M., Kawas, C. H., Kuller, L. H., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000313933.17796.f6 · Cited by 121
Wruck, C. J., Götz, M. E., Herdegen, T., Varoga, D. J., Brandenburg, L., & Pufe, T. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042499 · Cited by 117
Transforming growth factor‐βs inhibit mitogen‐stimulated proliferation of astrocytes
Hunter, K. E., Sporn, M. B., & Davies, A. M. (1993) · Glia · doi:10.1002/glia.440070303 · Cited by 114
Smad3–ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins
Bakin, A. V., Stourman, N. V., Sekhar, K. R., Rinehart, C., Yan, X. S., Meredith, M. J., Arteaga, C. L., & Freeman, M. L. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.033 · Cited by 105
Effects of Transforming Growth Factor β1 on Astroglial Cells in Culture
Toru‐Delbauffe, D., Baghdassarian-Chalaye, D., Gavaret, J. M., Courtin, F., Pomérance, M., & Pierre, M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02357.x · Cited by 86
Koponen, J. K., Kekarainen, T., Heinonen, S. E., Laitinen, A., Nystedt, J. M., Laine, J. T., & Ylä‐Herttuala, S. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300302 · Cited by 80
Self-citationOxidative stress-inducible lentiviral vectors for gene therapy
Hurttila, H., Koponen, J., Kansanen, E., Jyrkkänen, H.-K., Kivelä, A. M., Kylätie, R., Ylä‐Herttuala, S., & Levonen, A. (2008) · Gene Therapy · doi:10.1038/gt.2008.75 · Cited by 56
Self-citationOgita, K., Kubo, M., Nishiyama, N., Watanabe, M., Nagashima, R., & Yoneda, Y. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.002 · Cited by 15
Impaired spatial navigation learning in transgenic mice over-expressing heme oxygenase-1
Morgan, D., Holcomb, L. A., Saad, I., Gordon, M. N., & Maines, M. D. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00803-8 · Cited by 14
Cited by
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
Self-citationAn Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020) · Molecules · doi:10.3390/molecules25225474 · Cited by 1,388
Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory
Massaad, C. A., & Klann, E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3208 · Cited by 635
“Intrahippocampal injections of a lentiviral vector carrying the nuclear factor E2-related factor 2 (Nrf2) transcription factor improves spatial learning in the APP=PS1 mouse model of AD concomitant with a change in Ab solubility consistent with reduced Ab toxicity (207).”
BackgroundWhen NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595
“Activation of NF-kB is accomplished through phosphorylation of IkB by IkB kinases (IKKs), which leads to the release and nuclear translocation of NF-kB (22, 28, 150).”
Influential
Metadata
- Authors
- Kanninen, K., Heikkinen, R., Malm, T., Rolova, T., Kuhmonen, S., Leinonen, H., Ylä-Herttuala, S., Tanila, H., Levonen, A.-L., Koistinaho, M., & Koistinaho, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-09-22
- Volume
- 106
- Issue
- 38
- Pages
- 16505-16510
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2019172653
- Cited by
- 293
- References
- 38
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.